Abstract
The authors present the results of the examination of 61 patients with genitourinary space-occupying lesions, using 18F- fluorodeoxyglucose positron emission tomography (PET) in whole body mode. In all cases the diagnosis was verified morphologically. The results demonstrated high diagnostic accuracy of PET, including possibility to determine the extent of oncourological cancer. However, the method displays poor efficacy in cases of hypernephroid cancer due to low level of glycolysis in this type of tumor.
Publication types
-
Comparative Study
-
Evaluation Study
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Carcinoma, Embryonal / diagnostic imaging*
-
Carcinoma, Embryonal / pathology
-
Carcinoma, Embryonal / therapy
-
Carcinoma, Renal Cell / diagnostic imaging*
-
Carcinoma, Renal Cell / pathology
-
Carcinoma, Renal Cell / therapy
-
Choriocarcinoma / diagnostic imaging*
-
Choriocarcinoma / pathology
-
Choriocarcinoma / therapy
-
Data Interpretation, Statistical
-
Diagnosis, Differential
-
Fluorodeoxyglucose F18
-
Humans
-
Kidney / pathology
-
Kidney Neoplasms / diagnosis
-
Kidney Neoplasms / diagnostic imaging*
-
Kidney Neoplasms / pathology
-
Kidney Neoplasms / therapy
-
Lymph Node Excision
-
Lymphatic Metastasis
-
Male
-
Middle Aged
-
Neoplasm Metastasis
-
Positron-Emission Tomography*
-
Prostate / pathology
-
Prostate-Specific Antigen / blood
-
Prostatic Hyperplasia / diagnosis
-
Prostatic Hyperplasia / diagnostic imaging
-
Prostatic Neoplasms / blood
-
Prostatic Neoplasms / diagnosis
-
Prostatic Neoplasms / diagnostic imaging*
-
Prostatic Neoplasms / pathology
-
Prostatic Neoplasms / therapy
-
Radiopharmaceuticals
-
Seminoma / diagnostic imaging*
-
Seminoma / pathology
-
Seminoma / therapy
-
Sensitivity and Specificity
-
Testicular Neoplasms / diagnostic imaging*
-
Testicular Neoplasms / pathology
-
Testicular Neoplasms / therapy
-
Testis / pathology
Substances
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18
-
Prostate-Specific Antigen